Acute Physiological and Perceptual Responses to Novel Forms of High-intensity Interval Exercise
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03359928 |
|
Recruitment Status :
Completed
First Posted : December 2, 2017
Last Update Posted : September 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| High-intensity Interval Exercise Heart Rate Rating of Perceived Exertion Blood Pressure Acute Mood Physical Activity Enjoyment | Behavioral: Boxing Behavioral: Stair stepping Behavioral: Stair climbing | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 15 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | Using a randomised crossover trial design participants will be randomised computer assisted random sequence generation to sequences in which they are exposed to each experimental condition (exercise modality: stair stepping, stair climbing and non-contact boxing). |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Acute Physiological and Perceptual Responses to Novel Forms of High-intensity Interval Exercise |
| Actual Study Start Date : | November 20, 2017 |
| Actual Primary Completion Date : | April 30, 2018 |
| Actual Study Completion Date : | April 30, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Boxing
In each of the three sessions a different exercise modality will be conducted, in a randomised sequence. Non-contact boxing involves boxing "punch pads" that will be held by the one of the researchers, while wearing protective boxing gloves. Each exercise modality will be conducted following a high-intensity interval protocol (4 x 60 seconds of exercise interspersed with 60 seconds of rest). During each exercise bout participants will be encouraged to exercise at an intensity that elicits a heart rate of ≥85% of maximum, which will always be followed by 60 seconds of passive recovery. Participants will complete a 5 minute warm-up and a 2 minute cool down and stretch after the exercise bouts have been completed.
|
Behavioral: Boxing
as already discussed |
|
Experimental: Stair stepping
Participants will complete 3 sessions of exercise. In each of the three sessions a different exercise modality will be conducted in a randomised sequence. Stair stepping involves stepping on to and off a 35 cm Reebok exercise bench, repeatedly. Each exercise modality will be conducted following a high-intensity interval protocol (4 x 60 seconds of exercise interspersed with 60 seconds of rest). During each exercise bout participants will be encouraged to exercise at an intensity that elicits a heart rate of ≥85% of maximum, which will always be followed by 60 seconds of passive recovery. Participants will complete a 5 minute warm-up and a 2 minute cool down and stretch after the exercise bouts have been completed.
|
Behavioral: Stair stepping
as already discussed |
|
Experimental: Stair climbing
In each of the three sessions a different exercise modality will be conducted, in a randomised sequence. Stair climbing involves continuously ascending the stairs located in a public access staircase. Each exercise modality will be conducted following a high-intensity interval protocol (4 x 60 seconds of exercise interspersed with 60 seconds of rest). During each exercise bout participants will be encouraged to exercise at an intensity that elicits a heart rate of ≥85% of maximum, which will always be followed by 60 seconds of passive recovery. Participants will complete a 5 minute warm-up and a 2 minute cool down and stretch after the exercise bouts have been completed. |
Behavioral: Stair climbing
as already discussed |
- Heart rate [ Time Frame: 6 months ]Second-to-second heart rate monitoring throughout exercise sessions using wrist worn Polar A360 heart rate monitors
- Mood [ Time Frame: 6 months ]Acute mood state
- Enjoyment [ Time Frame: 6 months ]Physical activity enjoyment scale (PACES). Range of possible scores from 18-126, higher scores indicate higher enjoyment.
- RPE [ Time Frame: 6 months ]Rating of perceived exertion
- Blood pressure [ Time Frame: 6 months ]Measured using automatic blood pressure monitor
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- adult (≥18 years) employees
- no health conditions that preclude them from exercise and on no medication, information obtained via their self-report.
- able to understand written and spoken English.
- participants reporting that they are asthmatic will allowed to participate with medical clearance and instructed to bring their bronchodilator medication and use it when required.
Exclusion Criteria:
- symptoms of or known presence of heart disease
- condition or injury or co-morbidity affecting the ability to undertake exercise
- diabetes mellitus
- early family history of sudden cardiac death
- pregnancy or likelihood of pregnancy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03359928
| United Kingdom | |
| Teesside University | |
| Middlesbrough, United Kingdom | |
| Principal Investigator: | Kathryn Weston, PhD | Teesside University |
| Responsible Party: | Naomi Burn, Principal Investigator, Teesside University |
| ClinicalTrials.gov Identifier: | NCT03359928 |
| Other Study ID Numbers: |
162/17 |
| First Posted: | December 2, 2017 Key Record Dates |
| Last Update Posted: | September 11, 2018 |
| Last Verified: | September 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

